| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | Feb 13, 2024 | ||
| SC 13G | Report | Mar 3, 2023 | ||
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G | Report | SC 13G | Aug 12, 2022 | |
| SC 13G/A | Report | QUOIN PHARMACEUTICALS, LTD. | Mar 10, 2022 | |
| SC 13G/A | Report | AMENDED SC 13G | Feb 14, 2022 | |
| SC 13G | Report | QUOIN PHARMACEUTICALS LTD. | Feb 10, 2022 | |
| SC 13G | Report | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | Nov 12, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G | Report | CELLECT BIOTECHNOLOGY LTD. | Jan 13, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2020 | |
| SC 13G | Report | SC 13G | Jan 17, 2020 | |
| SC 13G | Report | CELLECT BIOTECHNOLOGY LTD. | Jan 10, 2020 | |
| SC 13G/A | Report | SABBY 13G-A APOP 1.03.20 | Jan 3, 2020 | |
| SC 13G | Report | SC 13G | Feb 19, 2019 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2019 | |
| SC 13G | Report | SABBY 13G APOP 2.12.19 | Feb 12, 2019 | |
| SC 13G/A | Report | SABBY 13G-A APOP 1.03.19 | Jan 3, 2019 | |
| SC 13G/A | Report | SC 13G/A | Feb 20, 2018 | |
| SC 13G | Report | SABBY 13G APOP 02.01.18 | Feb 1, 2018 | |
| SC 13G | Report | SCHEDULE 13G | May 9, 2017 | |
| SC 13G | Report | SC 13G | Mar 3, 2017 | |
| SC 13G | Report | SC 13G | Mar 3, 2017 | |
| SC 13G | Report | SC 13G | Feb 14, 2017 |